Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus
-
Fasenra granted US Orphan Drug Designation for eosinophilic oesophagitis
-
Breztri Aerosphere Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease
-
FDA grants Fast Track designation for Farxiga in chronic kidney disease
-
Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease
-
AstraZeneca agrees to buy US FDA Priority Review Voucher from Sobi
-
Update on the Phase III NEPTUNE trial of Imfinzi plus tremelimumab in Stage IV non-small cell lung cancer
-
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure
-
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer
-
Calquence granted US Breakthrough Therapy Designation for chronic lymphocytic leukaemia
Latest articles and press releases
All of our latest press releases and articles are available to explore
